Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Military Vaccine Agency's Medical Infectious Disease Research Program (MILVAX 10-1-111)
This publication has 12 references indexed in Scilit:
- Estimated global incidence of Japanese encephalitis:Bulletin of the World Health Organization, 2011
- Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51Vaccine, 2011
- Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51Vaccine, 2010
- Japanese Encephalitis in Travelers from Non-Endemic Countries, 1973–2008The American Journal of Tropical Medicine and Hygiene, 2010
- Evaluation of Chimeric Japanese Encephalitis and Dengue Viruses for Use in Diagnostic Plaque Reduction Neutralization TestsClinical and Vaccine Immunology, 2009
- Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51Vaccine, 2008
- Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2–3 September, 2004Vaccine, 2005
- Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccinesVaccine, 2000
- Test‐Based Exact Confidence Intervals for the Difference of Two Binomial ProportionsBiometrics, 1999
- Sensitivity of Two-Sample Permutation Inferences in Observational StudiesJournal of the American Statistical Association, 1990